The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 11.4 billion by 2027, according to a new report by Radiant Insights, Inc., registering a CAGR of 8.3% over the forecast period. Increasing pipelines for biological candidates, rising demand for additional analytical details on drugs, and process development by regulatory agencies are boosting the market growth.
Analytical testing helps in providing real-time product quality control along with optimizing and monitoring processes, characterizing biosimilars and biologics, and improving productivity. One of the main reasons for outsourcing analytical testing services is to benefit from skilled and experienced professionals, as well as to access expensive analytical equipment which are not available in-house.
Download Free Sample Report @ https://www.radiantinsights.com/research/pharmaceutical-analytical-testing-outsourcing-market/request-sample
Increased development of biologics is also creating a demand for analytical testing services. In the last three decades, biologics have taken the center stage in the discovery and development of drugs. Moreover, there is a high demand to define higher-order biological structures. The need for better product characterization, along with comparability studies, especially for biosimilars, further leads to drug companies outsourcing these services.
A patent cliff, particularly for small molecules in the pharmaceutical industry leads to a decline in revenue, thereby affecting profits. Over the next few years, several best-selling biologics would come toward the end of patent life, such as Humira. Drug innovators are therefore under constant pressure to bring new products through the pipeline at a faster rate. Developing advanced analytical testing to assess and monitor the quality attributes of these products requires a broader set of equipment and expertise, which is beyond the internal capacity of pharma companies. This would subsequently lead to increased instances of outsourcing pharmaceutical analytical testing services.
Further key findings from the report suggest:
• The outsourcing of clinical bioanalytical testing services emerged as the largest segment in 2019 with a share of around 79% owing to the increasing number of clinical trials
• The extractable and leachable services segment is expected to witness a significant growth rate owing to an increasing number of vendors offering these services at competitive prices
• North America dominated the global market with a share of 54.2% in 2019 as the region is one of the top manufacturing hubs of highly reliable, complex, and high-end pharmaceuticals
• Some of the players operating in the pharmaceutical analytical testing outsourcing market are Toxikon, Inc.; Intertek Group PLC; SGS SA; Eurofins Scientific; Boston Analytical; Pace Analytical Services, LLC; West Pharmaceutical Services, Inc.; Intertek Group Plc; Pharmaceutical Product Development, LLC; WuXi AppTec, Inc.; and Charles River Laboratories International, Inc.
Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/pharmaceutical-analytical-testing-outsourcing-market
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Radiant Insights internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Innovation
3.3.1.2. Regulation safety and quality
3.3.1.3. End-users volume
3.3.1.4. Pricing
3.3.2. Market Restraint Analysis
3.3.2.1. Data insecurity
3.3.2.2. Third party performance
3.3.3. Industry Challenges
3.4. Pharmaceutical Analytical Testing Outsourcing: Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier Power
3.4.1.2. Buyer Power
3.4.1.3. Substitution Threat
3.4.1.4. Threat from new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Environmental Landscape
3.4.2.3. Social Landscape
3.4.2.4. Technology Landscape
3.4.2.5. Legal Landscape
3.4.3. Major Deals & Strategic Alliances Analysis
Continued…
Read all Reports of this category @ https://www.radiantinsights.com/catalog/pharmaceutical
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assists and facilitate organizations and individuals procure market research reports, helping them in the decisions making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Toll Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco; State: California; Country: United States
Email: [email protected]
Website: https://www.radiantinsights.com/
Pharmaceutical analytical testing outsourcing is the constitution of services from the manufacturing, testing and validating the pharmaceuticals and therapeutics.
This involves validating pharmaceutical ingredient, compounds, manufacturing methods required for the development of these drugs.
Global pharmaceutical analytical testing outsourcing market is expected to rise to an estimated value of USD 10.42 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026.
Key players profiled in this report are: SGS SA; TOXIKON; Eurofins Scientific; Pace Analytical Services, LLC; Intertek Group plc; Pharmaceutical Product Development, LLC; Exova; Charles River; Boston Analytical; West Pharmaceutical Services, Inc.; Dalton Pharma Services; Merck KGaA; Cambrex Corporation; WuXi AppTec; Source BioScience; Ajinomoto Bio-Pharma; Catalent, Inc; Gateway AnalyticalDownload PDF Sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pharmaceutical-analytical-testing-outsourcing-marketSegmentation: Global Pharmaceutical Analytical Testing Outsourcing MarketGlobal Pharmaceutical Analytical Testing Outsourcing Market By Service Type (Bioanalytical Testing, Method Development & Validation, Stability Testing, Others)Product Type (Raw Materials, Finished Product, Active Pharmaceutical Ingredients),End-Users (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Industry)Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026Competitive Analysis: Global Pharmaceutical Analytical Testing Outsourcing Market Global pharmaceutical analytical testing outsourcing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
The report includes market shares of pharmaceutical analytical testing outsourcing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.Some of the key questions answered in this report:Detailed Overview of pharmaceutical analytical testing outsourcing market helps deliver clients and businesses making strategies.Influential factors that are thriving demand and constraints in the market.What is the market concentration?
Is it fragmented or highly concentrated?What trends, challenges and barriers will impact the development and sizing of pharmaceutical analytical testing outsourcing market?SWOT Analysis of each key players mentioned along with its company profile with the help of Porter’s five forces tool mechanism to compliment the same.What growth momentum or acceleration market carries during the forecast period?
Pharmaceutical analytical testing Outsourcing Market is the constitution of services from the manufacturing, testing and validating the pharmaceuticals and therapeutics.
This involves validating pharmaceutical ingredient, compounds, manufacturing methods required for the development of these drugs.
These outsourcing services are provided by specialized manufacturing organizations that are solely focused on outsourcing of these activities.pharmaceutical analytical testing outsourcing market is expected to rise to an estimated value of USD 10.42 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026.
This rise in market value can be attributed to the constrained budgets and the need for reducing the R expenses as well as manufacturing costs.The competitive analysis of the major market players studied in the Pharmaceutical Analytical Testing Outsourcing Market report, assists businesses take better moves for improving their product and sales.
The report contains the details about market analysis, market definition, market segmentation, key development areas, competitive analysis and research methodology.
This Pharmaceutical Analytical Testing Outsourcing Market report delivers the company profiles, product specifications, capacity, production value, and market shares of each company for the forecasted period of 2020-2027.
Pharmaceutical Analytical Testing Outsourcing Market is the constitution of services from the manufacturing, testing and validating the pharmaceuticals and therapeutics.
This involves validating pharmaceutical ingredient, compounds, manufacturing methods required for the development of these drugs.
These outsourcing services are provided by specialized manufacturing organizations that are solely focused on outsourcing of these activities.Global pharmaceutical analytical testing outsourcing market is expected to rise to an estimated value of USD 10.42 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026.
Get Sample Report at :https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pharmaceutical-analytical-testing-outsourcing-market Competitive Analysis: Global Pharmaceutical Analytical Testing Outsourcing MarketFew of the major competitors currently working in the global pharmaceutical analytical testing outsourcing market are SGS SA; TOXIKON; Eurofins Scientific; Pace Analytical Services, LLC; Intertek Group plc; Pharmaceutical Product Development, LLC; Exova; Charles River; Boston Analytical; West Pharmaceutical Services, Inc.; Dalton Pharma Services; Merck KGaA; Cambrex Corporation; WuXi AppTec; Source BioScience; Ajinomoto Bio-Pharma; Catalent, Inc; Gateway Analytical; Alcami Corporation; Aztech Sciences Inc.; Recro Gainesville and Next Breath, a division of AptarGroup Inc. Key Pointers Covered in the Global Pharmaceutical Analytical Testing Outsourcing Market Trends and Forecast to 2026Global Pharmaceutical Analytical Testing Outsourcing Market New Sales VolumesGlobal Pharmaceutical Analytical Testing Outsourcing Market Replacement Sales VolumesGlobal Pharmaceutical Analytical Testing Outsourcing Market Installed BaseGlobal Pharmaceutical Analytical Testing Outsourcing Market By BrandsGlobal Pharmaceutical Analytical Testing Outsourcing Market SizeGlobal Pharmaceutical Analytical Testing Outsourcing Market Procedure VolumesGlobal Pharmaceutical Analytical Testing Outsourcing Market Product Price AnalysisGlobal Pharmaceutical Analytical Testing Outsourcing Market Healthcare OutcomesGlobal Pharmaceutical Analytical Testing Outsourcing Market Cost of Care AnalysisGlobal Pharmaceutical Analytical Testing Outsourcing Market Regulatory Framework and ChangesGlobal Pharmaceutical Analytical Testing Outsourcing Market Prices and Reimbursement AnalysisGlobal Pharmaceutical Analytical Testing Outsourcing Market Shares in Different RegionsRecent Developments for Global Pharmaceutical Analytical Testing Outsourcing Market CompetitorsGlobal Pharmaceutical Analytical Testing Outsourcing Market Upcoming ApplicationsGlobal Pharmaceutical Analytical Testing Outsourcing Market Innovators StudyGet Detailed TOC:https://www.databridgemarketresearch.com/toc/?dbmr=global-pharmaceutical-analytical-testing-outsourcing-market Key Developments in the Market:In April 2019, Charles River announced that they had completed the acquisition of Citoxlab.
This acquisition will provide further expansion of geographical stronghold of Charles River due to Citoxlab’s expertise in providing CRO (Contract Research Organization) services to the North America and European region.
This acquisition is a strategic step as the trend for outsourcing pharmaceutical and biotechnology services is on the rise.In September 2018, Cambrex Corporation announced that they had completed the acquisition of Halo Pharma, adding formulation development and finished dosage manufacturing capabilities to the Cambrex service portfolio.
The global pharmaceutical analytical testing outsourcing market size was valued at USD 6.54 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.3% over the forecast period.
Innovation in the pharmaceutical industry, increasing focus on regulation, safety & quality, rising number of end-users, and pricing benefits of outsourcing are the key factors driving the market.The economic benefits associated with outsourcing these services and approvals in the pharmaceutical industry are projected to support market growth.
Quicker and reliable results, data safety, and improved efficiency are some key factors favoring market growth.
Due to competitive pressures, pricing concerns, and lead-time to market, companies are opting to outsource testing services.
According to the Pharma Intelligence Report 2019, the total development pipeline increased to 16,181 molecules in 2019 from 15,267 molecules in 2018.Key Player Mentioned:SGS SAToxikon, Inc.Eurofins ScientificPace Analytical Services, Inc.Intertek Group PlcPharmaceutical Product Development, LLC.WuXi AppTec, Inc.Boston AnalyticalFor Right Perspective & Competitive Insights, Request a Sample @: https://www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market/request/rs1 The economic benefits associated with outsourcing these services and approvals in the pharmaceutical industry are projected to support market growth.
According to the Pharma Intelligence Report 2019, the total development pipeline increased to 16,181 molecules in 2019 from 15,267 molecules in 2018.Product Segment Analysis: BioanalyticalMethod Development & ValidationStability TestingRegional Segment Analysis: North AmericaEuropeAsia PacificLatin AmericaMiddle East & Africa In several nations, analytical laboratories are considered to be a part of the essential healthcare infrastructure, thus analytical studies were continued with minimal or no initial disruptions due to COVID-19.
